NCT01831479View on ClinicalTrials.gov

Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

October 31, 2011

Conditions
Healthy
Interventions
DRUG

Rosuvastatin

Single administration of rosuvastatin 20mg tablet QD for 7 consecutive days

DRUG

Olmesartan

Single administration of olmesartan 40mg tablet QD for 7 consecutive days

DRUG

Rosuvastatin and olmesartan

Co-administration of rosuvastatin 20mg tablet and and olmesartan 40mg tablet QD for 7 consecutive days

Trial Locations (1)

120-752

Severance Hospital, Seoul

All Listed Sponsors
lead

Severance Hospital

OTHER

NCT01831479 - Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter